[ad_1]
Technological advances are one of the key factors in the growth of the global brain disease market. Scientists from the University of Utah Health and Stanford University have recently found a solution in the form of a targeted treatment that slows progression or improves two degenerative brain disorders, namely. ataxia and Lou Gehrig's disease, another name for amyotrophic lateral sclerosis (ALS).
The WHO has already estimated at one billion the number of people seeking treatment for neurological disorders in the world, but today there are fewer treatments. Although the need for treatment of brain diseases is urgent, highly targeted and non-invasive therapies, such as targeted ultrasound approved by the Food and Drug Administration (FDA), could attract attention. With the onset of a rare brain disorder called "rat lungworm disease" in the US state of Hawaii, the need for accurate and responsive treatments is expected to increase dramatically.
Get the report brochure @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=66
Some scientists argue that humans need less sleep with age, but such changes in sleep hours may worsen the disintegration badociated with brain disorders such as Alzheimer's disease. In addition, people over the age of 30 who suffer from lack of sleep and difficulty sleeping are at increased risk of brain disease. As a result, with the aging of the population over 30 years old and the growing risk of brain disorders, the growth of the global brain disease market could take a new impetus. Other factors that may contribute to the growth of the global brain disease market include the demand for brain monitoring devices and the increasing frequency of neurological disorders.
Global Brain Disease Market Overview
Any damage to the brain as a result of an injury or health problems – usually called brain disease – can take various forms, such as infections, trauma, tumors, convulsions, and strokes. Headaches, migraines, poor muscle control, memory problems, vision problems, vomiting or nausea are some of the most common symptoms of brain diseases.
Get the table of contents of the report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=66
Available treatments for various brain diseases depend on the diagnosis. Common treatments include drugs, surgery, radiation and chemotherapy.
Global Brain Disease Market: Key Segments and Analyzes
Depending on the type of infections, the market for brain diseases may involve meningitis and encephalitis. Meningitis is characterized by inflammation of the delicate membrane (meninges) that surrounds the brain and spinal cord. It is usually caused by a bacterial and viral infection. Encephalitis is characterized by inflammation of the brain tissue. Meningitis and encephalitis often occur together and are collectively called meningoencephalitis.
Based on the type of trauma, the brain disease market can be segmented into concussion, traumatic brain injury and hemorrhage. Concussions are extremely traumatic brain injuries that affect brain function and lead to loss of consciousness and headaches. Traumatic brain injury can lead to irreversible brain damage with mental retardation and can also result in alterations in the personality of the affected person. Bleeding in the brain caused by an injury or high blood pressure is called hemorrhage.
Based on the type of tumor, the brain disease market can be segmented into brain tumor, hydrocephalus and glioblastoma. Hydrocephalus is a condition characterized by an increase in the amount of cerebrospinal fluid in the skull, while a glioblastoma is a highly cancerous brain tumor that usually occurs in the adult brain.
Global Brain Disease Market: Geographic Analysis
Depending on the geography, the global brain disease market can be segmented into North America, Europe, Asia-Pacific and the rest of the world. In 2016, North America held the leading position in the market, followed by Europe. Key factors for both regions include an ever increasing prevalence of neurological diseases and a growing demand for technologically advanced medical equipment for treatment. According to the Central US Brain Tumor Registry, approximately 350,000 cases of brain and nervous system tumors have been recorded in the United States. European countries are also expected to show a stable rate of growth in the global brain disease market. In the coming years, the Asia-Pacific region is expected to post a remarkable growth in the brain disease market thanks to the rapid evolution of the health infrastructure and the increasing demand for advanced treatments. Among the other factors that could fuel market growth in Asia-Pacific, there is the growing awareness of various brain disorders and the increase in the number of patients with neurological disorders.
Read the full presentation of Report @ https://www.tmrresearch.com/brain-disease-market
Global market for brain diseases: the actors mentioned in the report
It is expected that, over time, more and more well-established players will appear in the global brain disease market. Medtronic, Inc., AstraZeneca plc, Hoffmann-La Roche Ltd., Boston Scientific Corporation, Sapiens Neuro and Omeros Corporation were among the leading players in the brain disease therapeutics market in 2016.
About us:
TMR Research is a leading provider of market research and tailored consulting services to companies that want to succeed in today's supercharged economy. With a team of experienced, dedicated and dynamic badysts, we are redefining the way our clients manage their business by providing authoritative and authoritative research studies adapted to the latest methodologies and market trends.
Contact us:
Rohit Bhisey
Chief of Internet Marketing
Tel: + 1-415-520-1050
Email: [email protected]
[ad_2]
Source link
